2-epoxy-4-vinylcyclohexane | 76123-08-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-epoxy-4-vinylcyclohexane
• 英文别名: 3-ethenylcyclohexan-1-ol
• CAS: 76123-08-5
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: ZYBGGGUBHNFAEV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  甲基磺酰氯 、 2-epoxy-4-vinylcyclohexane 以 二氯甲烷 为溶剂， 以83%的产率得到trans-3-vinylcyclohexyl methanesulfonate
  参考文献：
  名称：

  [EN] COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
  [FR] COMPOSÉS INHIBANT LA PROTÉINE MCL-1

  摘要：

  本文提供了髓样细胞白血病1蛋白（Mcl-1）抑制剂，其制备方法，相关的药物组合物，以及使用这些物质的方法。例如，本文提供了化合物I的公式，及其药用盐和含有这些化合物的药物组合物。本文提供的化合物和组合物可以用于治疗癌症等疾病或症状。

  公开号：

  WO2017147410A1
• 作为产物：
  描述：

  3-vinylcyclohexanone 在 L-Selectride 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以58%的产率得到2-epoxy-4-vinylcyclohexane
  参考文献：
  名称：

  [EN] COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
  [FR] COMPOSÉS INHIBANT LA PROTÉINE MCL-1

  摘要：

  本文提供了髓样细胞白血病1蛋白（Mcl-1）抑制剂，其制备方法，相关的药物组合物，以及使用这些物质的方法。例如，本文提供了化合物I的公式，及其药用盐和含有这些化合物的药物组合物。本文提供的化合物和组合物可以用于治疗癌症等疾病或症状。

  公开号：

  WO2017147410A1

文献信息

• DIEPOXY COMPOUND AND METHOD FOR PRODUCING SAME
  申请人：DAICEL CORPORATION

  公开号：US20150133629A1

  公开（公告）日：2015-05-14

  There is provided a diepoxy compound that can be polymerized to form a cured product having thermal stability that has excellent heat resistance, and can maintain excellent mechanical properties even if exposed to a high temperature environment. The saturated diepoxy compound of the present invention is represented by the following formula (1) and can be produced by hydrogenating the unsaturated bond of an unsaturated diepoxy compound represented by the following formula (2). In the following formulas, R 1 to R 20 are each an independent group and identically or differently represent a hydrogen atom, a methyl group, or an ethyl group.

  提供了一种双环氧化合物，可以聚合形成具有热稳定性的固化产物，具有优异的耐热性，并且即使暴露在高温环境下也能保持优异的机械性能。本发明的饱和双环氧化合物由以下式（1）表示，并且可以通过氢化下式（2）表示的不饱和双环氧化合物的不饱和键来制备。在以下式中，R1到R20分别是独立的基团，并且可以相同或不同地表示氢原子、甲基基团或乙基基团。
• Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
  申请人：Aventis Pharma Deutschland GmbH

  公开号：US20040198786A1

  公开（公告）日：2004-10-07

  Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals The invention relates to cycloalkyl derivatives having bioisosteric carboxylic acid groups and to their physiologically acceptable salts and physiologically functional derivatives. What is described are compounds of the formula 1, 1 in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistence is involved.

  环烷基衍生物具有生物等效羧酸基团，其制备方法及其作为药物的用途。本发明涉及具有生物等效羧酸基团的环烷基衍生物及其生理上可接受的盐和生理功能衍生物。所描述的化合物具有下式1,1中所定义的基团，以及它们的生理上可接受的盐和制备方法。这些化合物适用于治疗和/或预防脂肪酸代谢紊乱和葡萄糖利用障碍以及胰岛素抵抗相关的紊乱。
• CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS
  申请人：Meyer Imke

  公开号：US20130137710A1

  公开（公告）日：2013-05-30

  The present invention relates to the cosmetic, dermatological or therapeutic use of certain cyclohexyl carbamate compounds of formula (I) given below, preferably as anti-cellulite actives. The invention further relates to compositions and cosmetic, dermatological or therapeutic products comprising such compounds of formula (I), which are preferably suitable for the prophylaxis (prevention) and cosmetic treatment (combating) of cellulite in human beings, corresponding methods and novel compounds of formula (I) wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR 1 R 2 , wherein R 1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R 2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R 1 and R 2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring.

  本发明涉及以下式子（I）所示的某些环己基氨基甲酸酯化合物的化妆品、皮肤科或治疗用途，优选作为抗脂肪纹活性剂。本发明还涉及包含该式（I）化合物的组合物和化妆品、皮肤科或治疗产品，这些化合物优选用于人类的脂肪纹预防和美容治疗，以及相应的方法和新型式（I）化合物。其中，A表示......，X、Y和Z分别独立地表示氢、C1-C4烷基或C2-C4烯基，其中可选地，X、Y和Z中的两个基团彼此共价结合形成二环环系统，在这样的二环环系统中，X、Y和Z中的两个基团一起优选形成具有1至4个碳原子的基团，优选为具有1至3个碳原子的碳氢基团，B表示NR1R2，其中R1表示氢或具有1至14个碳原子的有机基团，R2表示具有1至14个碳原子的有机基团，可选地，R1和R2彼此共价结合，优选使得B为3至8个成员的环。
• Cyclohexyl carbamate compounds as anti-ageing actives
  申请人：Symrise AG

  公开号：EP2389922A1

  公开（公告）日：2011-11-30

  The present invention relates to the cosmetic, dermatological or therapeutic use of compounds of formula (I) given below, in particular as anti-ageing actives. wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR1R2, wherein R1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R1 and R2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring. The invention further relates to corresponding methods and to compositions and cosmetic, dermatological or pharmaceutical preparations (compositions) comprising one or more compounds of formula (I) and one or more further anti-ageing actives. The invention further relates to compounds of formula (I) as a drug, their use for the preparation of a pharmaceutical composition and to certain novel compounds of formula (I).

  本发明涉及以下式子(I)的化合物在化妆品、皮肤科或治疗中的使用，特别是作为抗衰老活性物质。 其中， A代表 其中，X、Y和Z分别独立地表示氢、C1-C4烷基或C2-C4烯基， 其中，可选地，X、Y和Z中的两个基团在形成二环环系的同时共价键合在一起，这样，在这样的二环环系中，X、Y和Z中的两个基团一起优选形成具有1到4个碳原子的基团，优选是指1到3个碳原子的碳氢基团， B代表NR1R2， 其中， R1代表氢或具有1到14个碳原子的有机基团， R2代表具有1到14个碳原子的有机基团， 并且可选地，R1和R2共价键合在一起，优选是使B成为3到8成员环。 本发明还涉及相应的方法、包含一个或多个式(I)化合物和一个或多个进一步的抗衰老活性物质的组合物和化妆品、皮肤科或制药制剂(组合物)。本发明还涉及式(I)化合物作为药物、其用于制备制药组合物以及某些新的式(I)化合物。
• LIGHT DIFFUSIVE POLYCARBONATE RESIN COMPOSITION AND LIGHT DIFFUSIVE PLATE USING SAID RESIN COMPOSITION
  申请人：Kogure Masami

  公开号：US20090080079A1

  公开（公告）日：2009-03-26

  The present invention provides a light-diffusive polycarbonate-based resin composition which includes (A) 100 parts by mass of an aromatic polycarbonate resin, (B) 0.01 to parts by mass of a light-diffusing agent, and (C) 0.1 to parts by mass of a styrene-(meth)acrylic ester copolymer, and a light-diffusing plate formed from the composition. The light-diffusive polycarbonate-based resin composition can be injection-molded to form a light-diffusing plate having satisfactory precision in thickness for use in comparatively large liquid crystal displays having a size larger than 20 inches.

  本发明提供了一种光扩散的基于聚碳酸酯的树脂组合物，包括（A）100份质量部的芳香族聚碳酸酯树脂，（B）0.01至份质量部的光扩散剂，以及（C）0.1至份质量部的苯乙烯-（甲基）丙烯酸酯共聚物，以及由该组合物形成的光扩散板。该光扩散的基于聚碳酸酯的树脂组合物可以注塑成形，形成具有满意的厚度精度的光扩散板，用于比20英寸更大的液晶显示器。